Kimball Hall

Kimball Hall has extensive work experience in the biotechnology industry, with a focus on executive roles in operations and manufacturing. Kimball served as the Chief Executive Officer at Innocoll Biotherapeutics starting in January 2023. Prior to that, they worked at Abzena as the President and Chief Operating Officer from December 2020 to January 2023, and as the Chief Operating Officer from October 2019 to December 2020.

Before Abzena, Kimball held the position of Global Head Biologics Drug Substance at Genentech from January 2016 to October 2019. Kimball also worked at Amgen for several years, serving as VP Manufacturing from July 2014 to January 2016, VP Corporate Manufacturing from January 2011 to January 2016, VP Operations from May 2006 to January 2011, and Sr Director Quality from January 2002 to May 2006.

Kimball Hall attended the University of Washington from 1984 to 1988 and obtained a Bachelor of Science degree in Microbiology.